Fraxodi and mixed hepatocellular-cholestatic injury Patient Reports February 09, 2010

Fraxodi Side Effects Report #5161747-5
Fraxodi side effect was reported by a Consumer or non-health professional from FRANCE on Nov 20, 2006. Male patient, 56 years of age, weighting 172.0 lb, was diagnosed with deep vein thrombosis  and was treated with Fraxodi. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cholestasis, mixed hepatocellular-cholestatic injury, transaminases increased. Fraxodi dosage: .7ML PER DAY. During the same period patient was treated with NICORETTE, NEXIUM, EFFERALGAN CODEINE, PREVISCAN, SOLUPRED, ATARAX. Patient was hospitalized. Patient recovered.